| Ketoprofen, paracetamol and placebo in the treatment of episodic tension-type headache. | |
| | |
MedLine Citation:
|
PMID: 8665578 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The aim of the study was to assess the efficacy and tolerability of a single oral dose of ketoprofen 25 mg in comparison with single doses of ketoprofen 2 x 25 mg, paracetamol 500 mg and 1,000 mg, and placebo in the treatment of episodic tension-type headache. The study was conducted as a single centre, double-blind, randomized, placebo-controlled, five-period, within-patient comparative trial in outpatients with episodic tension-type headache according to the International Headache Society's diagnostic criteria. Each patient had to treat five attacks of episodic tension-type headache with a single dose of each of the tested medications with a minimum interval of 72 h between two attacks. Details of the attack and response to treatment were recorded on a diary card. Altogether 30 patients treated 5 attacks and 2, 3, 1 and 4 patients treated 4, 3, 2 and 1 attack, respectively. The primary variable was decrease in headache pain intensity from baseline to 2 h after intake, evaluated by means of a 100 mm visual analogue scale. Ketoprofen 50 mg was significantly better than placebo and paracetamol for this main criterion. Neither of the paracetamol groups differed from the placebo group. Only a few adverse events were reported, usually of mild or moderate severity, with no difference between the treatments. Ketoprofen 50 mg may be considered an effective and well tolerated analgesic in the treatment of episodic tension-type headache of moderate or severe intensity. |
| | |
Authors:
|
C G Dahlöf; L D Jacobs |
Related Documents
:
|
12883248 - Histopathology of interval (delayed) appendectomy specimens: strong association with gr... 19040678 - Safety and tolerability of divalproex sodium extended-release in the prophylaxis of mig... 17013888 - Development and evaluation of the electromagnetic hypersensitivity questionnaire. 8792038 - Prophylaxis of migraine with oral magnesium: results from a prospective, multi-center, ... 21933428 - Early reduction in painful physical symptoms is associated with improvements in long-te... 11795678 - Clinical and biochemical effects of zileuton in patients with the sjögren-larsson synd... |
Publication Detail:
|
Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial |
Journal Detail:
|
Title: Cephalalgia : an international journal of headache Volume: 16 ISSN: 0333-1024 ISO Abbreviation: Cephalalgia Publication Date: 1996 Apr |
Date Detail:
|
Created Date: 1996-08-08 Completed Date: 1996-08-08 Revised Date: 2008-02-11 |
Medline Journal Info:
|
Nlm Unique ID: 8200710 Medline TA: Cephalalgia Country: NORWAY |
Other Details:
|
Languages: eng Pagination: 117-23 Citation Subset: IM |
Affiliation:
|
Gothenburg Migraine Clinic, Sociala Huset, Sweden. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Acetaminophen
/
adverse effects,
therapeutic use* Administration, Oral Adolescent Adult Aged Analgesics, Non-Narcotic / adverse effects, therapeutic use* Anti-Inflammatory Agents, Non-Steroidal / adverse effects, therapeutic use* Dose-Response Relationship, Drug Double-Blind Method Female Headache / drug therapy* Humans Ketoprofen / adverse effects, therapeutic use* Male Middle Aged Pain Measurement |
| Chemical | |
Reg. No./Substance:
|
0/Analgesics, Non-Narcotic; 0/Anti-Inflammatory Agents, Non-Steroidal; 103-90-2/Acetaminophen; 22071-15-4/Ketoprofen |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Pilot study of MK-462 in migraine.
Next Document: Primary low cerebrospinal fluid pressure syndrome with galactorrhea: findings at MR imaging.